- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04306055
Blood Donor Recruitment During Epidemic of COVID-19
Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China
Study Overview
Status
Conditions
Detailed Description
In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not.
Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc.
The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510095
- Guangzhou Blood Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Blood donors whose last donation were between 1 Feb to 31 March, 2019.
Exclusion Criteria:
- Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Questionnaire with precaution information
Questionnaire in this group includes information about precaution of blood donation during epidemic of COVID-19.
|
Ever blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19.
|
Experimental: Questionnaire without precaution information
Questionnaire in this group dose not include information about precaution of blood donation during epidemic of COVID-19.
|
Ever blood donors in this group would receive a questionnaire which dose not include the information above.
|
No Intervention: No questionnaire group
Ever donors in this group would not receive the questionnaire.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences of attitude about blood donation towards different questionnaires
Time Frame: 1 day
|
Compare participants' intention of blood donation after they read different information in the questionnaire.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rates of blood donation during 3 weeks
Time Frame: 3 weeks
|
Blood donation rate of 3 groups will be followed
|
3 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Blood donor recruitment
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Donation
-
International Institute of Rescue Research and...Unknown
-
Uppsala University HospitalRecruiting
-
DGTI - Haemapheresis Vigilance Working PartyAix ScientificsActive, not recruitingBlood Donation With Hemapheresis
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); University of Ghana; Syracuse... and other collaboratorsRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Bioheng Biotech Co., Ltd.Unknown
-
Guangzhou Blood CenterCompleted
-
Haemonetics CorporationCompletedRed Blood Cell DonationUnited States
-
HemanextCompletedWhole Blood Donation and LeukoreductionUnited States
-
National University Hospital, SingaporeUnknownAnonymous Donors at Blood Donation Center (NUH)Singapore
-
Guangzhou Blood CenterUnknown
Clinical Trials on Questionnaire with precaution information
-
Taipei Medical University WanFang HospitalNo longer availableValuable Suggestions to Improve Health Care Quality Transparent and Accessible Medical Care
-
University of BolognaCompleted
-
Philipps University Marburg Medical CenterCompleted
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
Hospital San Carlos, MadridCompleted
-
Johns Hopkins UniversityCenters for Disease Control and PreventionCompleted
-
The Hong Kong Polytechnic UniversityCompletedHealthy | Autism Spectrum DisorderHong Kong
-
University of GlasgowCompletedCancer ScreeningUnited Kingdom
-
KU LeuvenUniversitaire Ziekenhuizen KU Leuven; Research Foundation FlandersActive, not recruiting
-
Case Western Reserve UniversityCompletedSmoking Cessation | Food InsecurityUnited States